I’m Dr. Daniel Kim and it’s my honor to have the chance to you. Dealing with your health and the healthcare system is complicated, but I aim to make things simple and effective for you. I am board certified in Internal Medicine and Obesity Medicine and I specialize in complex illness in the older population and obesity medicine. I am also a diplomate in Clinical Homeopathy. I did my residency at nearby Harbor-UCLA Medical Center and I got my MD at UC San Diego. I was a partner physician at Kaiser Permanente West Los Angeles for nearly a decade practicing in the clinic, hospital, emergency room and ICU, and my interests were in preventing readmissions to the hospital and pneumonia.
Curriculum Vitae for Daniel Kim, MD MAS
714-794-2777
dkim@southlandwellness.net
Professional Experience
1. Owner. Southland Wellness. February 2022- Present
· Providing Direct Primary Care (DPC) and concierge medicine services to Rossmoor, Los Alamitos, Seal Beach, Cypress, Long Beach, etc.
· Providing Obesity Medicine services.
· Providing Clinical Homeopathy services.
· Providing Addiction Medicine servies.
· Providing home-based care.
2. Internal Medicine: Hospitalist, Transitional Care Clinic, Obesity Medicine Physician. Southern California Permanente Medical Group (SCPMG), Kaiser West Los Angeles Medical Center. September 2014-Present. (Partner September 2014 to August 2022)
· Readmission Committee Member July 2021- ongoing
· Recipient of funding for research from Regional Research Committee studying the effects of using a CURB65-based intervention to reduce community acquired pneumonia admissions 2018.
· Pneumonia Committee Champion 2017-2018.
· Continuing Medical Education Coordinator 2017-2018.
· Created a smartphase template for preoperative evaluations.
2. Chief Executive Officer. Chiyewon Co. Ltd. April 2018-2019
· Successfully led effort to obtain European certification (PCBC, Notified Body #1434) for a class III dental device (from a regulatory standpoint, equivalent to FDA approval for a device such as an orthopedic implant).
i. Personally composed hundreds of pages of reports, including systematic reviews of the scientific literature regarding bone grafts, zoonotic diseases, sterilization methods of medical devices, etc.
ii. Implemented deployment of quality management system compliant with ISO 13485.
· Implemented Lean Management principles into operations
· Directed hiring and staffing and operations
· Directed sales operations
3. Hospitalist. Harbor-UCLA Medical Center. July 2014-September 2014.
4. Hospice Physician, Hope International Hospice. Torrance, CA. July 2013-August 2014.
5. NIH Research Fellow. Department of Radiation Oncology, UCSD, La Jolla, CA and Fuster Lab VA La Jolla. July 2009- June 2011.
6. Teach For America, High School Teacher at Compton High School. Compton, CA. June 2003-June 2005.
Active Certifications, Licenses, Registrations
1. Diplomate, American Board of Internal Medicine (2014-present)
2. Diplomate, Board Certified American Board of Obesity Medicine (2023-present)
3. Physician and Surgeon License, California Medical Board, License No. A122585 (2012-present)
4. NPI No. 1174801344
5. DEA Registration No. FK3501928, XK3501928
6. Diplomate, Center for Education and Development of Clinical Homeopathy (2022-present)
Education
1. Resident, Internal Medicine. Harbor-UCLA Medical Center. June 2011-June 2014.
· Representative, Committee of Interns and Residents. June 2013-June 2014
o Participated in contract re-negotiations for interns and residents with Los Angeles County
o Procured Sonosite Ultrasound for Department of Medicine
2. Doctor of Medicine. UC San Diego, School of Medicine. June 2011. La Jolla, CA.
3. Master of Advanced Studies (M.A.S.) in Clinical Research. UC San Diego, June 2010. La Jolla, CA.
Master’s Thesis: Clinical Outcomes of Low-Stage Non-Small Cell Lung Cancer (NSCLC) and Metastatic Lung Disease Patients Treated With a Frameless Stereotactic Body Radiotherapy (SBRT) Approach.
4. Bachelor of Arts in Chemistry. Amherst College. May 2003. Amherst, MA.
Peer-Reviewed Publications:
1. Kim D, Eshtiaghpour D, Alpern J, Datta A, Eysselein V, Yee H. Access to Primary Care is Associated With Better Autoimmune Hepatitis Outcomes in an Urban County Hospital. BMC Gastroenterology. (2015) 15:91.
2. Kim D, Spellberg B. Does Real-Time Feedback to Residents With or Without Attendings Improve Medical Documentation? Hospital Practice (1995). (2014) 42:123-30.
3. Yin X, Johns S, Kim D… Fuster MM. Lymphatic Specific Disruption in the Fine Structure of Heparan Sulfate Inhibits Dendritic Cell Traffic and Functional T Cell Responses in the Lymph Node. Journal of Immunology. (2014) 192:2133-42.
4. Sandhu AP, Lau SK, Rahn D, Nath SK, Kim D, Song WY, Gulava S, Fuster MM, Bazhenova L, Mundt AJ. Stereotactic Body Radiation Therapy in Octogenarians With Stage I Lung Cancer. Clin Lung Cancer. (2014) 15:131-5.
5. Kim D, Fuster MM, Nath SK, Bharne A, Read W, Bazhenova L, Song W, Mundt AJ, Sandhu AP. Clinical outcomes following image-guided stereotactic body radiation for pulmonary oligometastases. Journal of Radiosurgery and SBRT. (2012) 2: 63-72.
6. Kim D, Lyoo KS, Smith D, Hur W, Hong SW, Sung PS, Yoon SK, Mehta S. Number of mutations within CTL-defined epitopes of the hepatitis B Virus (HBV) core region is associated with HBV disease progression. J Med Virol. Dec 2011;83(12):2082-7.
7. Nath SK, Sandhu AP, Jensen L, Kim D, Bharne A, Nobiensky PD, Lawson JD, Fuster MM, Bazhenova L, Song WY, Mundt AJ. Frameless image-guided stereotactic body radiation therapy for lung tumors with 4-dimensional computed tomography or 4-dimensional positron emission tomography/ computed tomography. Clin Lung Cancer. 2011 May;12(3):180-6.
8. Nath SK, Sandhu AP, Kim D, Bharne A, Nobiensky PD, Lawson JD, Fuster M, Bazhenova L, Song WY, Mundt AJ. Locoregional and distant failure following image-guided stereotactic body radiation for early-stage primary lung cancer. Radiother Oncol. 2011 Apr;99(1):12-7.
9. Kim SY, Hur W, Choi JE, Kim D, Wang JS, Yoon HY, Piao LS, Yoon SK. Functional characterization of human oncoprotein gankyrin in zebrafish. Experimental and Molecular Medicine. Jan 2009; 41(1):8-16.
Abstracts
1. Does Real-Time Resident or Attending Feedback Improve Medical Documentation? (First author). Committee of Residents and Physicians Resident Physician Summit: “Shaping Healthcare in Los Angeles.” October 19, 2013. Los Angeles, CA.
a. Honorable Mention Winner
b. Data presented to executive committee of Harbor-UCLA Medical Center.
2. Autoimmune Hepatitis Outcomes In An Urban County Hospital With A Largely Hispanic Population. (First author) Program No. P1445. ACG 2013 Annual Scientific Meeting Abstracts. San Diego, CA: American College of Gastroenterology.
3. Type B Lactic Acidosis in Lymphoma: A Poor Prognostic Factor. (First author). Presented at the American College of Physicians Southern California Chapters I, II, III Poster Competition, October 27, 2012. La Jolla, CA.
4. Prevalence of Obstructive Coronary Artery Disease Found on Cardiac Computed Tomographic Angiography (First author). Presented at Solomon Scholars Poster Presentation, June 5, 2012. Los Angeles, CA
5. Frameless 4DCT-Guided Stereotactic Body Radiotherapy With Daily Image Guidance for Oligometastatic Pulmonary Disease: Clinical Outcomes. (First author) Presented at the Chicago Multidisciplinary Symposium in Thoracic Oncology 2010 in Chicaco, IL.
6. Local Control for Primary versus Metastatic Lung Cancer using Stereotactic Body Radiotherapy at 48 Gy in Four Fractions. (First author). Presented at the American Society for Radiation Oncology 2010 meeting in San Diego, CA.
7. Frameless 4DCT-Guided Stereotactic Body Radiotherapy with Daily Image Guidance for Early Stage Lung Cancer: Clinical Outcomes. (Third author). Presented at the American Society for Radiation Oncology 2010 in San Diego, CA.
8. Using Microarray Analysis to Find Differential Expression of Genes and Proteins in Leishmania Amazonensis.” Abstract presented at NIH Summer Research Grant Poster presentation in November 2006 at UCSD, La Jolla, CA.
9. Chiang N, Takano T, Gronert K, Kim D, and Serhan CN. Lipoxin A4 receptor evokes ligand specific responses with lipid and peptide mediators. Abstract presented at Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation, and Related Diseases Conference, Nashville, TN, October 2001.